Step 1 of 4

25%

Please note any questions below with (Required) are mandatory.

Section 1: General Information

1. Contact information:
b-d. Address(Required)
2. Would your agency like to be considered for fully subsidized naloxone in exchange for a monthly data reporting schedule to DPH? (Select one)(Required)
By selecting “no”, your agency is indicating that they you will purchase naloxone at the state-negotiated public interest price, instead of the no-cost ordering option. Agencies that purchase the naloxone from DPH are required to provide data reports annually.
3. Please select the program type(s) that best describes your agency: (select all that apply)(Required)
4. Is the address listed above (in question 1) the only location where CNP-obtained naloxone will be delivered? (select one)(Required)
Please note that shipping naloxone to addresses in more than one town/city will have data reporting implications. DPH will discuss this more during onboarding.
5. Will the naloxone obtained through the CNP be available to individuals who do not access your agency’s other services? (select one)(Required)
6. Does your agency have a pharmacy that is (or could be) utilized to dispense naloxone to patients or clients? (select one)(Required)

Section 2: Program Activities

Section 3: Program protocol

Please attach a single PDF or Word document that contains the information listed below. Applications that do not include a protocol will not be processed until it is received.  A signed Affiliate Hospital Medical Director (AHMD) letter is only required for emergency medical services.

Drop files here or
Accepted file types: pdf, doc, docx, Max. file size: 5 MB, Max. files: 4.

    a) A proposed protocol for your agency’s CNP-related processes

    The outline protocol should include outline the following components: 

    • Roles of key staff members  
    • Protocols detailing how: 
    • Recipients will be identified, trained, and provided with naloxone  
    • Naloxone inventory will be stored, tracked, and maintained  
    • Data collection will be performed for the following metrics: 
    • Number of naloxone doses distributed  
    • Number of persons trained individual naloxone distribution encounters 
    • Number of overdose reversals reported back to program  
    • Number of fentanyl test strips distributed (if applicable) 
    • On-site or outreach overdose response policy

    b) If you selected “EMS Naloxone Leave-Behind Program” in Section 1, Question 3 of the application, please include a signed letter from your agency’s Affiliate Hospital Medical Director (AHMD)

    This letter must state that your agency has met the conditions for participation in leave-behind naloxone, outlined in the Massachusetts Medical Services Statewide Treatment Protocols.

    Section 4: Attestation

    1. All applicants must attest to the following, in order to be considered as an affiliate program for CNP: (must select all)

    Consent(Required)
    Consent(Required)

    DPH Core Competencies for OEND Programs

    Consent(Required)
    Consent(Required)
    Consent(Required)
    Consent(Required)
    Consent(Required)
    Consent(Required)